Ida Tin

Who they are

Ida Tin is Lead of the SPRIND Hormone Challenge at Germany's federal breakthrough-innovation agency — she co-founded Clue in 2012, coined the term 'FemTech', and is writing a book about the industry she named.

Person

Ida Tin trained at KaosPilots in Denmark — a school built around entrepreneurship and creative business — which set the tone for everything that followed. Possibly — she ran a small crystal-bead jewelry business during her studies, an early taste of making and selling before the bigger bets. In 2012 she co-founded Clue, a period and cycle tracking app she built into one of the leading female health platforms with 11 million monthly active users; along the way she coined the term 'FemTech', effectively naming and legitimising an entire category. She served as Clue's CEO for a long tenure before transitioning to Chairwoman, and has since moved into her current role leading the SPRIND Hormone Challenge — Germany's federal agency for breakthrough innovation. She was named one of Fast Company's 100 Most Creative People in 2016, is a listed keynote speaker on FemTech and women's health, and appeared on the Women Disrupting Tech podcast in early 2026. On LinkedIn she writes persistently about hormonal health, data privacy, and the funding gap for women in tech — not aspirational content, but pointed commentary, including public criticism of how competitors like Flo handle user data. The through-line is someone who builds institutions — a company, a category, now a government challenge — rather than just products.

Company

SPRIND's most recent major move is the Next Frontier AI Challenge, opened for applications in April 2026: a €125 million, 24-month structured competition to identify and build up to three European frontier AI labs from scratch, with selected teams potentially eligible to raise up to €1 billion in additional capital by June 2028. In May 2026, SPRIND also launched the Bürger-Hackathon, a citizen-facing hackathon to develop solutions for everyday problems in Germany, running across seven phases through the end of the year. The agency is headquartered in Leipzig, has approximately 50 employees, and operates with a yearly budget of approximately €250 million funded by the German government. Rafael Laguna de la Vera is SPRIND's Director.

Market

SPRIND sits at the intersection of public funding and deep-tech venture — Germany's answer to DARPA, tasked with backing breakthrough innovations that the private market underweights. Its recent moves position it explicitly in response to Europe's AI gap: the agency has warned that without a strong European presence in frontier AI, the region risks technological dependency on U.S. and Chinese models. SPRIND is also partnering with the U.S. National Science Foundation's Directorate for Technology, Innovation and Partnerships (NSF TIP) to co-accelerate key technology areas, signalling a transatlantic rather than purely European stance.

Network

No direct edges are available in the claims. Ida Tin's professional orbit is visible from context: Rafael Laguna de la Vera is Director of SPRIND and her institutional counterpart, and her long tenure at Clue means her closest collaborators are likely drawn from the European FemTech and digital health world she helped build.

Rafael Laguna de la Vera· Director, SPRIND

How they likely show up

Long tenure as CEO at Clue (founded 2012, multi-year run before transitioning to Chairwoman) → thinks in company-building arcs, not quarterly cycles.
Coined the term 'FemTech' and moved from operator to category advocate → comfortable shaping the frame, not just executing within it.
Active LinkedIn writer on hormonal health, data privacy, and funding gaps — including pointed public criticism of a named competitor → engages publicly with specifics and isn't afraid of friction.
Trained at KaosPilots (entrepreneurship and creative business) rather than a conventional university → likely values unconventional problem framing and experiential learning over credentials.
Moved from private company CEO to leading a government-backed innovation challenge → signals comfort operating at systemic or policy scale, not just product scale.
Writing a book about FemTech alongside an active institutional role → carries multiple long-horizon projects simultaneously, high agency.

Conversation tips

→ Reference the hormonal data or health equity angles specifically — her public writing goes deep on these; generic 'women's health' framing will feel thin.
→ Ask about the transition from running Clue to the SPRIND Hormone Challenge — moving from private founder to government innovation lead is a deliberate choice worth understanding.
→ She's on record about data privacy failures in women's health apps; if you work in digital health, come prepared to discuss your own data practices.
→ The KaosPilots background is a real differentiator — she'll likely appreciate interlocutors who are curious about unconventional education and institution-building.
→ Don't treat FemTech as a niche — she named the category and has spent over a decade arguing it's mainstream infrastructure; meet her at that level.

Toolbox

Openers

Open on the SPRIND Hormone Challenge — she moved from co-founding and running Clue to leading a government-backed challenge on hormonal health, which is a very deliberate second act worth asking about.
She is writing a book about FemTech and her experiences in the industry — it's in progress and she's posted about it on LinkedIn; asking where it stands is a concrete, informed opener.
She publicly called out Flo Health by name on LinkedIn over data privacy — referencing that specific post signals you've done the work and opens the conversation on where the industry still falls short.

Discovery questions

You coined 'FemTech' over a decade ago — where do you think the category has actually moved the needle on women's health infrastructure, and where has it mostly been noise?
The SPRIND Hormone Challenge is a government-funded mechanism rather than a VC-backed one — what does that structure let you do that the private market couldn't or wouldn't?
You've written publicly about the funding gap for women in tech and data privacy in health apps — how much of what you're building at SPRIND is a direct response to what you couldn't fix from inside Clue?

Avoid

Don't pitch FemTech as an untapped market opportunity — she invented the term and has spent years arguing the gap is a structural failure, not a discovery waiting to happen.

Make it yours